phrykt

BIO-TECHNE Corp (TECH): who owns it and who trades it

As of Nov 16, 2026, TECH insiders reported 2 open-market sales worth $437K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Amy E. Herr (Director), with $437K. 7 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling BIO-TECHNE

From the latest filings

Overall: more selling than buying. Insiders mostly sold. Funds and famous investors were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns TECH

592 funds and institutions reported TECH shares worth $12.4B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 9.0%.

Funds and institutions (13F) about 100%Everyone else 0%

10 largest owners, by share of the company

BlackRock, Inc.9.0%
FMR LLC (Fidelity)8.2%
Vanguard Capital Management LLC6.5%
Goldman Sachs Group Inc4.7%
Hbk Investments L P4.4%
Vanguard Portfolio Management LLC4.2%
Morgan Stanley4.1%
State Street Corp3.8%
Geode Capital Management, LLC3.4%
Invesco Ltd.3.2%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
BlackRock, Inc.14.03M8.96%$991M+14%
FMR LLC (Fidelity)12.79M8.17%$904M+62%
Vanguard Capital Management LLC10.22M6.53%$722M+0%
Goldman Sachs Group Inc7.34M4.69%$519M+278%
Hbk Investments L P6.83M4.36%$482M–
Vanguard Portfolio Management LLC6.51M4.16%$460M+0%
Morgan Stanley6.37M4.07%$450M-25%
State Street Corp5.98M3.82%$423M+2%
Geode Capital Management, LLC5.35M3.42%$378M+5%
Invesco Ltd.4.99M3.18%$352M+9%
Ruane, Cunniff & Goldfarb L.P.3.35M2.14%$237M-1%
Snyder Capital Management L P3.16M2.02%$224M+68%
Neuberger Berman Group LLC2.84M1.82%$201M-15%
Massachusetts Financial Services Co2.75M1.75%$194M-26%
Mairs & Power Inc2.70M1.72%$191M-2%
Capital Research Global Investors2.62M1.67%$185M-18%
UBS Group AG2.48M1.58%$175M-19%
Dimensional Fund Advisors LP2.25M1.44%$159M+14%
Whitebox Advisors LLC2.10M1.34%$148M–
Sumitomo Mitsui Trust Group, Inc.2.07M1.32%$146M+1%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, TECH insiders reported $0 of open-market purchases and $437K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$437K
2 trades, 1 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
May 8, 2026
Filed May 12, 2026

Purchases and sales by month

$320K$320KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
May 8, 2026Amy E. HerrDirectorSale6,636$48.28$320KForm 4
Feb 17, 2026Amy E. HerrDirectorSale1,976$59.11$117KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Amy E. HerrDirector–$437KMay 8, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

TECH short interest

Low short interest. 4.9% of TECH shares are sold short: about 1 share in 20. Over the last 12 reports the number of shares short went down 47%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 7.70M TECH shares were sold short, 4.9% of the shares outstanding, up 2.0% from the report before. At the average daily volume of 2.82M shares, buying them all back would take about 2.7 trading days (days to cover).

Shares short, % of all shares

4.91%May 15Oct 3012.8%

Days to cover

2.7May 15Oct 306.9

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20267.70M4.91%+2%2.82M2.7
Oct 15, 20267.55M4.81%+2%2.62M2.9
Sep 30, 20267.39M4.72%+11%3.56M2.1
Sep 15, 20266.63M4.23%+13%2.49M2.7
Aug 31, 20265.89M3.76%-9%2.36M2.5
Aug 14, 20266.46M4.13%-30%2.85M2.3
Jul 31, 20269.28M5.93%-23%3.96M2.3
Jul 15, 202612.12M7.74%-24%5.34M2.3
Jun 30, 202615.92M10.17%-13%10.81M1.5
Jun 15, 202618.20M11.63%+31%2.96M6.2
May 29, 202613.85M8.84%-5%2.79M5.0
May 15, 202614.55M9.29%+9%3.96M3.7

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Members of Congress who traded TECH

Since Nov 17, 2024, 3 members of Congress reported 6 purchases and 8 sales of TECH. The latest was a sale by April McClain Delaney on Apr 8, 2026, reported May 6, 2026.

Purchases 6Sales 8

Reported trades

Trade dateMemberTypeAmountOwnerReportedSource
Apr 8, 2026April McClain Delaney (D-MD)Sale$1K–$15KChildMay 6, 2026Report
Mar 26, 2026April McClain Delaney (D-MD)Partial sale$1K–$15KChildApr 6, 2026Report
Feb 24, 2026April McClain Delaney (D-MD)Partial sale$1K–$15KChildMar 10, 2026Report
Jan 28, 2026April McClain Delaney (D-MD)Partial sale$1K–$15KChildFeb 2, 2026Report
Dec 5, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildJan 5, 2026Report
Dec 2, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildJan 5, 2026Report
Oct 22, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildNov 4, 2025Report
Aug 1, 2025April McClain Delaney (D-MD)Partial sale$1K–$15KChildSep 2, 2025Report
May 26, 2025April McClain Delaney (D-MD)Partial sale$1K–$15KChildJul 2, 2025Report
Apr 29, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildMay 2, 2025Report
Apr 9, 2025April McClain Delaney (D-MD)Purchase$1K–$15KChildMay 2, 2025Report
Apr 8, 2025Robert P. Bresnahan, Jr. (R-PA)Sale$1K–$15KSelfMay 8, 2025Report
Apr 1, 2025Julie Johnson (D-TX)Sale$1K–$15KJointMay 14, 2025Report
Feb 25, 2025Robert P. Bresnahan, Jr. (R-PA)Purchase$1K–$15KSelfMar 27, 2025Report

Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work

BIO-TECHNE company events

BIO-TECHNE filed 9 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 4, 2026.

  1. Nov 4, 2026AnnouncementA copy of the press release issued by Bio-Techne Corporation on November 3, 2026, announcing a cash dividend is attached hereto as Exhibit 99.1. ​ ​ Item 9.01 Financial Statements and Exhibits ​ (d) Exhibits 99.1 Press Release, dated November 3, 2026, announcing cash dividend ​ ​ 104 Cover Page… Filing
  2. Sep 23, 2026VoteReported shareholder vote results. Filing
  3. Sep 14, 2026AnnouncementAs previously disclosed, on June 25, 2026, Bio-Techne Corporation, a Minnesota corporation, entered into an Agreement and Plan of Merger with Merck KGaA, Darmstadt, Germany, a German corporation with general partners and EMD Holdings NewCo, Inc., a Minnesota corporation and a wholly-owned… Filing
  4. Aug 12, 2026AnnouncementA copy of the press release issued by Bio-Techne Corporation on August 12, 2026 announcing a cash dividend is attached hereto as Exhibit 99.2. ​ Item 9.01 Financial Statements and Exhibits ​ (d) Exhibits 99.1 Press Release, dated August 12, 2026, announcing results of operations 99.2 Press Release… Filing
  5. Jun 26, 2026LeadershipIn connection with the contemplated Merger, the Compensation Committee of the Board approved cash retention bonus awards to each of the Company’s current named executive officers pursuant to retention agreements in order to encourage the Company’s named executive officers to remain with the Company… Filing
  6. Jun 25, 2026AnnouncementShared information with investors. Filing
  7. May 6, 2026AnnouncementA copy of the press release issued by Bio-Techne Corporation on May 6, 2026 announcing a cash dividend is attached hereto as Exhibit 99.2. ​ Item 9.01 Financial Statements and Exhibits ​ (d) Exhibits 99.1 Press Release, dated May 6, 2026, announcing results of operations 99.2 Press Release, dated… Filing
  8. Feb 11, 2026LeadershipBio-Techne Corporation announced that Dr. Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment, will be transitioning from his role, effective March 1, 2026, and will remain with Bio-Techne for a period of time to support a smooth transition. Filing
  9. Feb 4, 2026AnnouncementA copy of the press release issued by Bio-Techne Corporation on February 4, 2026 announcing a cash dividend is attached hereto as Exhibit 99.2. ​ Item 9.01 Financial Statements and Exhibits ​ (d) Exhibits 99.1 Press Release, dated February 4, 2026, announcing results of operations 99.2 Press… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

BIO-TECHNE financials

Famous investors that hold TECH

7 of the 50 well-known investors we track reported holding TECH in their latest 13F filing. The largest position is Israel Englander's, worth $297M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 20264.09M$297M0.2%+314%
Lee Ainslie · Maverick CapitalQ3 20261.54M$111M0.9%No change
Paul Tudor Jones · Tudor Investment CorpQ3 2026855,749$62M0.3%-9%
Ken Griffin · Citadel AdvisorsQ3 2026110,875$8M0.0%-89%
Steve Cohen · Point72 Asset ManagementQ3 202669,524$5M0.0%New
Larry Robbins · Glenview Capital ManagementQ3 202635,839$2.6M0.0%-39%
Jim Simons · Renaissance TechnologiesQ3 202612,900$935K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named TECH in the last 120 days.

FiledHolderFormStake
Nov 5, 2026FMR LLC13G/A0.7%
Nov 5, 2026FMR LLC13G/A0.7%

Questions about BIO-TECHNE Corp (TECH) stock

Who owns the most TECH stock?

The largest reported owner of BIO-TECHNE Corp (TECH) is BlackRock, Inc., with 9.0% of the company. In total, 592 funds and institutions reported holding TECH at the end of Q2 2026, together about 100% of the shares. See the largest owners.

Are TECH insiders buying or selling?

In the last 12 months, TECH insiders reported no open-market purchases and 2 sales worth $437K. The latest trade was on May 8, 2026. See every trade.

What is the short interest in TECH?

As of Oct 30, 2026, 7.70M TECH shares were sold short, 4.9% of the shares outstanding, up 2.0% from the report before. At the average daily volume of 2.82M shares, buying them all back would take about 2.7 trading days (days to cover). See the history.

Have members of Congress traded TECH?

Yes. 3 members of Congress reported 6 purchases and 8 sales of TECH since Nov 17, 2024. The latest was reported on May 6, 2026. See the trades.

Which famous investors hold TECH?

7 of the 50 well-known investors we track reported TECH in their latest 13F filing, including Israel Englander, Lee Ainslie, Paul Tudor Jones. The largest position is worth $297M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.